Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,982,221
+$5,430,828 QoQ
Shares Held
480,076
+34.5% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 256 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. RLAY ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in RLAY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,982,221 | 480,076 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,551,393 | 356,924 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $1,421,700 | 410,896 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $975,564 | 372,353 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,258,416 | 305,441 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,957,280 | 276,452 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,432,607 | 219,725 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,736,427 | 450,172 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,059,568 | 459,543 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $800,766 | 95,216 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,108,520 | 88,258 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,719,418 | 104,397 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,262,086 | 84,477 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,907,780 | 85,283 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,424,688 | 85,056 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,186,506 | 73,054 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,993,017 | 64,898 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,361,307 | 43,175 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,448,634 | 39,591 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,257,863 | 36,386 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,841,648 | 44,313 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,952,538 | 45,845 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||